Koninklijke Philips N.V.

€27.33As of Sun 8 Nov 2026, 12:00 UTC

AMS:PHIAHealthcare

Country Netherlands

PE (Fwd) •••

TSR 10Y CAGR 3.01%

Div yield 3.11%

ROE 8.61%

Medical Devices

Beta (5Y) 0.81

PE TTM 27.91

TSR TTM 19.78%

Mkt cap €26.72B

ROIC 6.60%

SE Grade™

Value

Quality

Moat

Consensus

Reference

€31

14.76%

(52.53%)

Hold 1|11|6|3|0

TTM

FYE 31 Dec EUR

FY2016

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026E

Trend

10Y

Peers

3.597

Revenue€B

4.105

4.093

4.092

4.151

4.183

4.212

4.279

4.325

4.283

4.367

3.715

0.86%

0.97%

7.32

Revenue growth%

14.95

13.87

13.74

13.32

11.74

13.74

13.01

12.88

11.68

9.33

27.80

12.88

13.17

11.66

Gross margin%

9.37

7.89

7.65

5.23

7.67

5.56

7.81

9.07

7.77

10.72

25.64

7.81

7.79

13.05

Operating margin%

30.38

29.00

27.24

26.58

26.22

28.21

25.71

23.92

21.11

21.14

23.59

23.92

26.40

8.70

Net margin%

6.30

4.26

4.94

6.55

5.21

3.89

3.00

0.40

0.70

9.41

0.70

4.08

18.51

P/E ratio (avg)x

7.356

6.686

7.299

6.909

7.047

7.298

8.258

8.768

9.122

10.20

37.13

8.768

7.328

21.85

EV/EBITx

46.12

44.82

52.39

55.60

62.21

72.42

79.83

76.44

79.00

91.25

31.04

79.00

67.31

21.70

FCF yield (avg)%

16.72

14.20

13.14

13.60

14.29

12.37

10.43

10.55

12.11

14.16

25.77

12.11

13.37

23.14

FCF margin%

4.01

1.09

0.94

2.63

4.17

1.72

3.14

2.11

2.97

3.17

9.90

2.97

2.80

1.591

FCF / Net incomex

0.170

0.188

0.185

0.194

0.191

0.177

0.180

0.195

0.210

0.201

0.810

0.195

0.189

28.33

ROIC%

19.27

19.61

21.46

23.46

23.82

23.00

22.23

21.66

20.57

17.92

13.83

21.66

21.56

18.23

Return on equity%

11.78

9.98

9.25

6.27

7.51

5.85

6.61

5.83

2.95

0.54

15.73

5.83

6.44

4.79

Return on assets%

29.50

29.21

27.87

29.49

27.59

26.60

28.57

29.89

30.03

29.78

9.91

29.78

29.35

1.39

EPS€

1.05

1.13

1.19

1.24

1.26

1.50

1.66

1.94

2.22

2.24

1.42

12.19%

7.62%

—

5.40

EPS growth%

5.80

3.86

6.25

4.46

4.39

6.68

3.70

5.19

5.59

5.26

6.22

5.26

5.22

1.82

Bookvalue per sh€

1.94

1.72

1.67

1.84

1.76

1.60

1.74

1.70

1.76

1.93

2.94

1.88%

(0.68%)

—

2.62

FCF per share€

0.79

0.88

0.94

1.01

1.21

1.35

1.47

1.56

1.83

2.15

0.63

12.27%

11.40%

—

0.48

Dividend per sh€

0.55

0.60

0.64

0.66

0.63

0.59

0.90

(2.04%)

1.30%

—

23.18

Div yield (avg)%

32.53

30.18

28.51

30.87

28.17

27.66

27.48

29.36

32.34

31.48

19.23

29.36

29.77

16.24

Payout ratio%

28.14

25.38

25.63

24.49

23.10

24.70

22.53

21.72

21.94

20.79

21.43

21.94

23.79

0.970

Shares (diluted)B

1.218

1.328

1.331

1.336

1.394

1.453

1.568

1.647

1.912

2.078

0.989

8.32%

5.64%

18.13

Buyback yield%

30.63

32.60

32.09

34.92

33.34

35.77

34.04

32.38

33.25

32.59

3.37

33.25

32.93

0.619

D/E ratiox

0.821

0.911

0.968

1.150

1.213

1.332

1.460

1.751

1.729

1.961

1.420

1.729

1.272

2.470

Enterprise value€B

1.382

1.569

1.729

1.641

1.712

1.721

1.753

1.743

1.898

1.881

3.448

1.90%

3.43%

2.159

LT debt€B

1.216

1.388

1.497

1.521

1.446

1.372

1.526

1.486

1.454

1.636

4.117

2.50%

2.85%

Peers (US$30.00B)

Cap (US$)

argenx SE

57.29B

32.08x

Qiagen N.V.

10.39B

27.27x

NewAmsterdam Pharma…

2.267B

—

DexCom, Inc.

29.62B

31.14x

Capital

TTM

10Y

Leveragex

1.705

(0.011)

EBIT/Intx

1.337

0.200

0.220

Own earn%

63.13

(45.96)

(46.23)

Sh yield%

41.31

63.43

62.97

Owners

Insiders/Inst%

6.57

21.68

Short interest%

5.15

SBC / revenue%

5.75

Record

10Y

Profitable years

10/10

Revenue growth years

10/10

EPS growth years

10/10

Dividend streakyrs

Op margin range%

21–30

$1 testx

−0.1

Incr. ROIC%

−3

Koninklijke Philips N.V. operates as a leading global healthcare technology enterprise with a presence across North America and numerous international markets. Its operations are organized into three primary divisions: Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses.

Growth vs revenue

Latest

Trend

10Y CAGR

Rel growth

Revenue

€4.367B

0.97%

1.00×

Cost of revenue

€3.057B

0.97%

1.00×

Operating expenses

€732.4M

1.44%

1.05×